Protocol Ledger

NCT04229004 · Phase III · COMPLETED

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Interventional Phase III clinical trial protocol NCT04229004 sponsored by Pancreatic Cancer Action Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-01-31 Enrollment: 502 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04229004
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)502 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04229004
Protocol FieldVerified Registry Value
NCT IdentifierNCT04229004
Consolidated Lead SponsorPancreatic Cancer Action Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment502 participants (ACTUAL)
Registered Start Date2020-01-31
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI